Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,326 | 2,172 | 1,863 | 874 | 457 |
| Gross Profit | 1,326 | 2,172 | 1,863 | 874 | 457 |
| Operating Expenses | 33,242 | 32,072 | 24,067 | 18,718 | 13,413 |
| Operating Income | -31,916 | -29,900 | -22,204 | -17,844 | -12,956 |
| Other Income | 3,476 | 4,726 | 4,597 | 4,096 | 2,393 |
| Pre-tax Income | -28,440 | -25,174 | -17,607 | -13,748 | -10,563 |
| Net Income Continuous | -28,440 | -25,174 | -17,607 | -13,748 | -10,563 |
| Net Income | $-28,440 | $-25,174 | $-17,607 | $-13,748 | $-10,563 |
| EPS Basic Total Ops | -0.76 | -0.74 | -0.51 | -0.54 | 16.16 |
| EPS Basic Continuous Ops | -0.77 | -0.74 | -0.51 | -0.54 | 16.16 |
| EPS Diluted Total Ops | -0.76 | -0.74 | -0.51 | -0.54 | 16.16 |
| EPS Diluted Continuous Ops | -0.77 | -0.74 | -0.51 | -0.54 | 16.16 |
| EPS Diluted Before Non-Recurring Items | -0.81 | -0.74 | -0.51 | N/A | N/A |
| EBITDA(a) | $-34,575 | $-32,125 | $-22,515 | $-18,255 | $-13,380 |